The role of ELANE in cartilage degradation and bone re-modelling has been well-established in rheumatoid arthritis and osteoarthritis (20) (OA), but its expression in chondrocytes of the EGP and its involvement in growth attenuation during IBD is a novel contribution of this study. Here, ELANE is linked to inflammatory bowel disease.